
$500,000,000 4.550% Senior Notes due 2028$500,000,000 5.400% Senior Notes due 2033 Global Payments Inc. (“Global Payments” or the “Company”) is offering $500,000,000 principal amount of its 4.550%Senior Notes due 2028 (the “2028 notes”) and $500,000,000 principal amount of its 5.400% Senior Notes due 2033 (the “2033notes” and, together with the 2028 notes, the “notes”). The 2028 notes will mature on March15, 2028, and the 2033 notes willmature on March15, 2033, in each case, unless earlier redeemed or repurchased by us. Global Payments will pay interest on thenotes semi-annually in arrears on March15 and September15 of each year, beginning on September15, 2026. The Company may, at its option, redeem each series of the notes, in whole or in part, at any time and from time to time atthe applicable redemption prices described in this prospectus supplement in “Description of the Notes — Optional redemption.”The Company must offer to repurchase the notes upon the occurrence of a Change of Control Repurchase Event (as defined in“Description of the Notes — Change of control”) at the price described in this prospectus supplement in “Description of theNotes — Change of control.” The notes will be our unsecured and unsubordinated indebtedness and will rank equally in right of payment with all of ourfuture unsecured and unsubordinated indebtedness from time to time outstanding. Each series of the notes is a new issue of securities with no established trading market. The Company has no intention toapply to list the notes on any securities exchange or to seek their admission to trading on any automated quotation system. Investing in the notes involves risks. See section entitled “Risk Factors” beginning on pageS-4of this prospectus supplementand the risk factors incorporated by reference into this prospectus supplement and the accompanying prospectus. Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapprovedof these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Anyrepresentation to the contrary is a criminal offense. (1)Plus accrued interest if any, from March12, 2026, if settlement occurs after that date. We expect to deliver the notes to investors in registered book-entry only form through the facilities of The Depository TrustCompany (“DTC”) on or about March12, 2026. Beneficial interests in the notes will be shown on, and transfers thereof will beeffected only through, records maintained by DTC and its direct and indirect participants, including Clearstream Banking, S.A.and Euroclear Bank S.A./N.V., as operator of the Euroclear System. TABLE OF CONTENTS PROSPECTUS SUPPLEMENT PageABOUT THIS PROSPECTUS SUPPLEMENTS-iiWHERE YOU CAN FIND MORE INFORMATIONS-iiiFORWARD-LOOKING STATEMENTSS-vSUMMARYS-1RISK FACTORSS-4USE OF PROCEEDSS-7CAPITALIZATIONS-8DESCRIPTION OF THE NOTESS-9CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONSS-26UNDERWRITINGS-30VALIDITY OF THE NOTESS-36EXPERTSS-36 PROSPECTUS ABOUT THIS PROSPECTUS1WHERE YOU CAN FIND MORE INFORMATION2FORWARD-LOOKING STATEMENTS3THE COMPANY3INDUSTRY AND MARKET DATA4RISK FACTORS4USE OF PROCEEDS4DESCRIPTION OF DEBT SECURITIES, COMMON STOCK, PREFERRED STOCK ANDDEPOSITARY SHARES4LEGAL MATTERS4EXPERTS5 ABOUT THIS PROSPECTUS SUPPLEMENT This document has two parts. The first part is this prospectus supplement, which describes the specificterms of this offering. The second part is the accompanying prospectus, which provides more generalinformation, some of which may not apply to this offering. You should read the entire prospectussupplement, as well as the accompanying prospectus and the documents incorporated by reference that aredescribed under “Where You Can Find More Information” in this prospectus supplement and theaccompanying prospectus. In the event that the description of the offering in this prospectus supplement isinconsistent with the accompanying prospectus, you should rely on the information contained in thisprospectus supplement. We have not, and the underwriters have not, authorized any other person to provide you with differentor additional information other than that contained or incorporated by reference in this prospectussupplement, the accompanying prospectus and any free writing prospectus that we have authorized for usein connection with this offering. We are not, and the underwriters are not, making an offer to sell thesesecurities in any jurisdiction where the offer or sale is not permitted. You should not assume that theinformation contained in or incorporated by reference into this prospectus supplement, the accompanyingprospectus and any free writing prospectus filed by us with the SEC is accurate as of any date other than itsrespective date. Our business, financial condition, liquidity, results of operations and prospects may havechanged since those dates. Unless otherwise specified or unless the context requires othe